Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Provider Givebacks On Hold Until 2003; AdvaMed Anticipates Scaled-Back Bill

This article was originally published in The Gray Sheet

Executive Summary

Congress is expected to wait until it passes a prescription drug bill before addressing Medicare provider "giveback" legislation in 2003

You may also be interested in...



Device User Fee Advocate Gregg To Assume Senate HELP Chairmanship

FDA's ability to adhere to device user fee performance goals will be closely monitored in the 108th Congress under a Senate HELP Committee led by Sen. Judd Gregg (R-N.H.)

2003 OPPS Final Rule Alleviates Payment Reductions For Device Procedures

Medicare's hospital outpatient prospective payment system (OPPS) reimbursement rate for APC 0107 (insertion of cardioverter defibrillators) will decrease by 12% under the 2003 final rule, released Nov. 1

Sen. Cleland Opposes DME Competitive Bidding Practice In Letter To Daschle

The newly formed Coalition for Access to Medical Services, Equipment and Technology (CAMSET) has a congressional ally in Sen. Max Cleland (D-Ga.)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017504

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel